(Q50535633)

15 March 2018

title

PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro. (English)

1 reference

15 March 2018

1 reference

1 reference

Yi-ming Ma

1

1 reference

15 March 2018

Rong-ya Tao

2

1 reference

15 March 2018

Qian Liu

3

1 reference

15 March 2018

Juan Li

4

1 reference

15 March 2018

Jin-ying Tian

5

1 reference

15 March 2018

Xiao-lin Zhang

6

1 reference

15 March 2018

Zhi-yan Xiao

7

1 reference

15 March 2018

Fei Ye

8

1 reference

15 March 2018

publication date

21 May 2011

1 reference

15 March 2018

Molecular and Cellular Biochemistry

published in

1 reference

15 March 2018

volume

357

1 reference

15 March 2018

issue

1-2

1 reference

15 March 2018

page(s)

65-72

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1007/s11010-011-0876-4

exact match

0 references

cites work

The developmental origins, mechanisms, and implications of metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Mechanisms linking obesity with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Insulin resistance, dyslipidemia, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Signalling mechanisms linking hepatic glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Protein tyrosine phosphatase 1B inhibitors for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Utilization of fluorescence tracer in hyperinsulinemic-euglycemic clamp test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Non-alcoholic fatty liver disease and the metabolic syndrome: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Animal models of steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Regulation of the expression of lipogenic enzyme genes by carbohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0876-4

Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21603884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21603884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21603884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-011-0876-4

1 reference

15 March 2018

1 reference

15 March 2018